CM
ADAP

Crestline Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Crestline Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-39,489
Closed -$67K – 202
2022
Q2 		$67K Sell
39,489
-511
-1% -$867 0.01% 215
2022
Q1 		$82K Buy
+40,000
New +$82K 0.01% 249